LUMYKRAS 240 mg film-coated tablets

DRUG2 trials

Sponsors

Deciphera Pharmaceuticals Inc., Asociacion Grupo Tratamiento De Tumores Digestivos

Conditions

Advanced Solid TumorAdvanced pancreatic adenocarcinomaMetastatic Solid TumorNon-Small Cell Lung Cancer

Phase 1

A Phase 1/2, First in Human Study of DCC-3116 as Monotherapy and in Combination With RAS/MAPK Pathway Inhibitors in Patients With Advanced or Metastatic Solid Tumors With RAS/MAPK Pathway Mutations

CompletedCTIS2022-501474-19-00

Deciphera Pharmaceuticals Inc.Advanced Solid Tumor, Metastatic Solid Tumor, Non-Small Cell Lung Cancer

End: 2025-09-12Target: 76Updated: 2025-06-13

Sotorasib combined with first-line chemotherapy for advanced pancreatic adenocarcinoma with KRAS p.G12C mutation

RecruitingCTIS2024-516233-12-00

Asociacion Grupo Tratamiento De Tumores DigestivosAdvanced pancreatic adenocarcinoma

Start: 2025-08-08Target: 15Updated: 2025-12-26